Bausch + Lomb

In News

Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers - Yahoo Finance

Yahoo Finance - Aug 29, 2026

Bausch + Lomb progresses dry eye candidate to Phase III despite mixed data - Clinical Trials Arena

Clinical Trials Arena - Aug 26, 2026

Bausch + Lomb Advances Dry Eye Combination and BL1332 Ocular Pain Programs - Eyewire+

Eyewire+ - Aug 25, 2026

Bausch + Lomb advances dual-action dry eye drop to phase 3, reports positive BL1332 pain data - Ophthalmology Times

Ophthalmology Times - Aug 26, 2026

Bausch + Lomb advances dry eye disease drug to Phase 3 despite mid-stage fail - BioSpace

BioSpace - Aug 25, 2026

Bausch + Lomb flops in ph. 2 with Xiidra and Miebo but advances combo to ph. 3 - Fierce Pharma

Fierce Pharma - Aug 25, 2026

Bausch + Lomb dry eye combo drop advances to phase 3 evaluation - Glance by Eyes On Eyecare

Glance by Eyes On Eyecare - Aug 27, 2026

Bausch + Lomb advances 2 first-in-class eye health therapies - Optometry Times

Optometry Times - Aug 25, 2026

Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PR Newswire

PR Newswire - Aug 06, 2026

Bausch + Lomb (BLCO) Stock Trades Below Fair Value As Caution Lingers - Yahoo Finance UK

Yahoo Finance UK - Aug 29, 2026

Exclusive: Bausch + Lomb plans Phase 3 trial for dry eye drop, despite missing mid-stage goal - Endpoints News

Endpoints News - Aug 24, 2026

Bausch + Lomb gives up on glaucoma eye drop hopeful after fail - Fierce Biotech

Fierce Biotech - Jul 10, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment